PamGene is a Dutch biotechnology company founded in 2000 and with headquarters in Den Bosch, NL. The company offers research services with a unique and proprietary microarray platform for functional proteomics activity profiling and cell signaling analysis. PamGene develops therapy response prediction biomarkers for candidate drugs and other active ingredients as well as diagnostic applications for a number of immuno-oncological targets. PamGene’s microarray technology is used in a broad range of applications in pharmaceutical research and in (pre)clinical development to gain insights into disease development and basic research. The company consists of 31 employees.
PamGene International B.V.
Contactpersoon035 – 7 506 127